Nasdaq · CIK 0001327607
MYFW First Western Financial Inc
Insider trading from SEC Form 4. Last filing 41 d ago. Close $29.91 on Oct 12, 2026, +35% from the 52-week low and -13% from the high.
In brief
First Western Financial Inc (MYFW) has 59 SEC Form 4 filings on file from 13 insiders, the latest filed on Sep 2, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $306k, net -$306k.
18 open-market trades have been scored at MYFW. The newest: Scott C Wylie (CHAIRMAN, CEO AND PRESIDENT) sold $306k of stock on Aug 31, 2026, filed Sep 2, 2026, scored 39 (weak). The largest of the 18 shown: Scott C Wylie (CHAIRMAN, CEO AND PRESIDENT) sold $416k on Dec 12, 2025, scored 41 (moderate). 2 insiders sold within 14 days of each other around Jan 26, 2026.
2 Form 144 notices of planned sales are on file, the latest filed May 20, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at First Western Financial Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $306k 10,000 shares | -1% | - | |
| 37Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $182k 6,417 shares | -1% | +40% from low-3% from high | |
| 30Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $31k 1,083 shares | -0% | +40% from low-3% from high | |
| 37Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $215k 7,500 shares | -1% | +44% from low0% from high | |
| 43Moderate | Scott C Mitchell director sell | $100k 4,093 shares | -48% | +45% from low-6% from high | |
| 55Moderate | David R Duncan director sell | $221k 8,626 shares | -100% | +45% from low-6% from high | |
| 52Moderate | David R Duncan director sell | $92k 3,668 shares | -219% | +40% from low-10% from high | |
| 53Moderate | David R Duncan director sell | $111k 4,406 shares | -72% | +42% from low-8% from high | |
| 21Weak | Luke A Latimer director sell | $42k 1,646 shares | -3% | +47% from low-0% from high | |
| 41Moderate | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $416k 16,171 shares | -2% | +46% from low-0% from high | |
| 28Weak | Julie A Courkamp CHIEF OPERATING OFFICER sell | $76k 2,933 shares | -5% | +47% from low0% from high | |
| 21Weak | Mark L Smith director sell | $42k 1,646 shares | -3% | +47% from low-0% from high | |
| 35Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $118k 5,000 shares | -1% | +35% from low-4% from high | |
| 35Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $118k 5,000 shares | -1% | +34% from low-5% from high | |
| 35Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $105k 5,000 shares | -1% | +19% from low-8% from high | |
| 35Weak | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT sell | $108k 5,000 shares | -1% | +23% from low-3% from high | |
| 34Weak | David R Duncan director sell | $88k 4,380 shares | -36% | - | |
| 36Weak | David R Duncan director sell | $164k 8,600 shares | -49% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 20, 2026 | Wylie Scott C Officer, Director | 7,500 0.08% of outstanding | $214k | May 20, 2026 | none |
| May 7, 2026 | Wylie Scott C Officer, Director | 7,500 0.77% of outstanding | $216k | May 4, 2026 | none |
Transactions
The newest 50 of 115 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | SOpen-market sale Common Stock | -10,000 | $30.55 | $306k | 740,312 | 41 d ago |
| Jun 3, 2026 | Patrick H Hamill director | AGrant or award Common Stock | +974 | $0.00 | $0 | 165,229 | Jun 5, 2026 |
| Jun 3, 2026 | Mark L Smith director | AGrant or award Common Stock | +974 | $0.00 | $0 | 53,626 | Jun 5, 2026 |
| Jun 3, 2026 | Thomas A Gart director | AGrant or award Common Stock | +974 | $0.00 | $0 | 25,493 | Jun 5, 2026 |
| Jun 3, 2026 | Scott C Mitchell director | AGrant or award Common Stock | +974 | $0.00 | $0 | 5,482 | Jun 5, 2026 |
| Jun 3, 2026 | Joseph C. Zimlich director | AGrant or award Common Stock | +974 | $0.00 | $0 | 42,079 | Jun 5, 2026 |
| Jun 3, 2026 | Luke A Latimer director | AGrant or award Common Stock | +974 | $0.00 | $0 | 57,547 | Jun 5, 2026 |
| Jun 3, 2026 | Ellen S. Robinson director | AGrant or award Common Stock | +974 | $0.00 | $0 | 2,907 | Jun 5, 2026 |
| Jun 3, 2026 | Julie A Caponi director | AGrant or award Common Stock | +974 | $0.00 | $0 | 23,571 | Jun 5, 2026 |
| Jun 3, 2026 | David R Duncan director | AGrant or award Common Stock | +974 | $0.00 | $0 | 44,652 | Jun 5, 2026 |
| May 22, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | SOpen-market sale Common Stock | -6,417 | $28.31 | $182k | 750,312 | May 26, 2026 |
| May 20, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | SOpen-market sale Common Stock | -1,083 | $28.52 | $31k | 756,729 | May 22, 2026 |
| May 1, 2026 | Matthew C. Cassell CHIEF REVENUE OFFICER | AGrant or award Common Stock | +862 | $0.00 | $0 | 16,664 | May 5, 2026 |
| May 1, 2026 | Julie A Courkamp CHIEF OPERATING OFFICER | AGrant or award Common Stock | +3,940 | $0.00 | $0 | 61,169 | May 5, 2026 |
| May 1, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | AGrant or award Common Stock | +7,005 | $0.00 | $0 | 768,659 | May 5, 2026 |
| May 1, 2026 | David R. Weber Chief Financial Officer | AGrant or award Common Stock | +668 | $0.00 | $0 | 6,707 | May 5, 2026 |
| May 1, 2026 | Matthew C. Cassell CHIEF REVENUE OFFICER | FTax withholding Common Stock | -388 | $28.55 | $11k | 16,276 | May 5, 2026 |
| May 1, 2026 | Julie A Courkamp CHIEF OPERATING OFFICER | FTax withholding Common Stock | -1,072 | $28.55 | $31k | 60,097 | May 5, 2026 |
| May 1, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | FTax withholding Common Stock | -1,907 | $28.55 | $54k | 766,752 | May 5, 2026 |
| May 1, 2026 | David R. Weber Chief Financial Officer | FTax withholding Common Stock | -240 | $28.55 | $6,852 | 6,467 | May 5, 2026 |
| May 4, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | FTax withholding Common Stock | -1,440 | $28.55 | $41k | 765,312 | May 5, 2026 |
| May 4, 2026 | David R. Weber Chief Financial Officer | FTax withholding Common Stock | -102 | $28.55 | $2,912 | 6,365 | May 5, 2026 |
| May 4, 2026 | Matthew C. Cassell CHIEF REVENUE OFFICER | FTax withholding Common Stock | -36 | $28.55 | $1,028 | 16,240 | May 5, 2026 |
| May 4, 2026 | Julie A Courkamp CHIEF OPERATING OFFICER | FTax withholding Common Stock | -417 | $28.55 | $12k | 59,680 | May 5, 2026 |
| May 5, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | SOpen-market sale Common Stock | -7,500 | $28.70 | $215k | 757,812 | May 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -2,013 | $23.56 | $47k | 6,588 | Feb 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -100 | $24.69 | $2,469 | 6,488 | Feb 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -582 | $24.49 | $14k | 5,906 | Feb 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -224 | $24.80 | $5,555 | 5,682 | Feb 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -100 | $24.78 | $2,478 | 5,582 | Feb 5, 2026 |
| Jan 26, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -159 | $24.83 | $3,948 | 5,423 | Feb 5, 2026 |
| Feb 4, 2026 | Scott C Mitchell director | SOpen-market sale Common Stock | -915 | $26.00 | $24k | 4,508 | Feb 5, 2026 |
| Feb 3, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan Revocable Trust | -2,000 | $25.50 | $51k | 6,626 | Feb 4, 2026 |
| Feb 3, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan Revocable Trust | -3,000 | $25.55 | $77k | 3,626 | Feb 4, 2026 |
| Feb 3, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan Revocable Trust | -3,626 | $25.61 | $93k | 0 | Feb 4, 2026 |
| Jan 28, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan GST Exempt Marital Trust | -1,674 | $24.95 | $42k | 0 | Jan 29, 2026 |
| Jan 28, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan Revocable Trust | -1,994 | $24.95 | $50k | 8,626 | Jan 29, 2026 |
| Jan 27, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan GST Exempt Marital Trust | -1,381 | $24.99 | $35k | 4,699 | Jan 28, 2026 |
| Jan 27, 2026 | David R Duncan director | SOpen-market sale Common Stockindirect: Sara C. Duncan GST Exempt Marital Trust | -3,025 | $25.17 | $76k | 1,674 | Jan 28, 2026 |
| Jan 5, 2026 | Julie A Courkamp CHIEF OPERATING OFFICER | AGrant or award Common Stock | +2,142 | $0.00 | $0 | 57,958 | Jan 6, 2026 |
| Jan 5, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | AGrant or award Common Stock | +7,766 | $0.00 | $0 | 764,248 | Jan 6, 2026 |
| Jan 5, 2026 | David R. Weber Chief Financial Officer | AGrant or award Common Stock | +113 | $0.00 | $0 | 6,077 | Jan 6, 2026 |
| Jan 5, 2026 | Julie A Courkamp CHIEF OPERATING OFFICER | FTax withholding Common Stock | -729 | $26.65 | $19k | 57,229 | Jan 6, 2026 |
| Jan 5, 2026 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | FTax withholding Common Stock | -2,594 | $26.65 | $69k | 761,654 | Jan 6, 2026 |
| Jan 5, 2026 | David R. Weber Chief Financial Officer | FTax withholding Common Stock | -38 | $26.65 | $1,013 | 6,039 | Jan 6, 2026 |
| Dec 16, 2025 | Luke A Latimer director | MOption exercise Common Stock | +1,697 | $25.00 | $42k | 58,219 | Dec 17, 2025 |
| Dec 16, 2025 | Luke A Latimer director | SOpen-market sale Common Stock | -1,646 | $25.78 | $42k | 56,573 | Dec 17, 2025 |
| Dec 16, 2025 | Luke A Latimer director | MOption exercise Stock Option Right to Buyderivative | -1,697 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 12, 2025 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | MOption exercise Common Stock | +16,500 | $25.00 | $413k | 772,653 | Dec 16, 2025 |
| Dec 12, 2025 | Scott C Wylie CHAIRMAN, CEO AND PRESIDENT | SOpen-market sale Common Stock | -16,171 | $25.72 | $416k | 756,482 | Dec 16, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Julie A Caponidirector
- Matthew C. CassellCHIEF REVENUE OFFICER
- Julie A CourkampCHIEF OPERATING OFFICER
- David R Duncandirector
- Thomas A Gartdirector
- Patrick H Hamilldirector
- Luke A Latimerdirector
- Scott C Mitchelldirector
- Ellen S. Robinsondirector
- Mark L Smithdirector
- David R. WeberChief Financial Officer
- Scott C WylieCHAIRMAN, CEO AND PRESIDENT
- Joseph C. Zimlichdirector
Questions about MYFW
Answered from the filings on this page, as of the latest one.
Are insiders buying MYFW?
As of Sep 2, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $306k by 1 insider at First Western Financial Inc in the last 90 days, net -$306k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade MYFW on the open market?
Scott C Wylie (CHAIRMAN, CEO AND PRESIDENT) sold $306k of MYFW on Aug 31, 2026 and filed the Form 4 on Sep 2, 2026. InsiderTell scored 39 (weak).
How many insiders file Form 4 at First Western Financial Inc?
13 people have filed a Form 4 at First Western Financial Inc, among them Julie A Caponi (director), Matthew C. Cassell (CHIEF REVENUE OFFICER), Julie A Courkamp (CHIEF OPERATING OFFICER). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.